tiprankstipranks
Trending News
More News >
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Income Statement

Compare
1,447 Followers

Black Diamond Therapeutics Income Statement

Last quarter (Q4 2024), Black Diamond Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Black Diamond Therapeutics's net income was $-15.98M. See Black Diamond Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -437.00K$ -3.24M$ -2.22M$ -600.00K
Operating Expenses
$ 78.78M$ 86.46M$ 92.83M$ 126.87M$ 69.57M
Depreciation and Amortization
$ 0.00$ 437.00K$ 3.24M$ 2.22M$ 600.00K
EBITDA
$ -78.78M$ -86.02M$ -92.32M$ -126.67M$ -66.65M
Operating Income
$ -78.78M$ -86.46M$ -92.83M$ -126.87M$ -69.57M
Other Income/Expenses
$ 9.11M$ 4.02M$ 1.66M$ 1.28M$ 2.32M
Pretax Income
$ -69.68M$ -82.44M$ -88.92M$ -125.60M$ -67.25M
Net Income
$ -69.68M$ -82.44M$ -84.52M$ -123.20M$ -65.48M
Per Share Metrics
Basic EPS
$ -1.27$ -1.88$ -2.33$ -3.40$ -1.99
Diluted EPS
$ -1.27$ -1.88$ -2.33$ -3.40$ -1.99
Weighted Average Shares Outstanding
55.03M 43.95M 36.33M 36.19M 32.91M
Weighted Average Shares Outstanding (Diluted)
55.03M 43.95M 36.33M 36.19M 32.91M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis